- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: May 23, 2025
- Last Updated: July 23, 2026
In short. Blue Fin Vision® provides consultant ophthalmic-led xanthelasma removal in Hatfield at One Hatfield Hospital, giving patients across Hertfordshire the same consultant-led pathway as our London clinics, closer to home.
Hertfordshire Convenience, Consultant-Led Care
Because xanthelasma sits on the eyelid, the safe choice is consultant ophthalmic-led care that protects the lid margin and a natural contour. Our Hatfield clinic at One Hatfield Hospital brings private xanthelasma removal in Hatfield to Hertfordshire, with the same consultant-led pathway as our London sites, so there is no need to travel into central London.
Patients visit our Hatfield clinic from across Hertfordshire, including Hatfield, St Albans, Welwyn Garden City, Hertford, Stevenage, Potters Bar, Barnet and the surrounding towns.
What Xanthelasma Is, in Brief
Xanthelasma in Hatfield is a benign, cholesterol-rich plaque on the eyelids that does not usually affect sight¹. It does not mean you definitely have high cholesterol, but because it can be linked with lipid abnormalities and cardiovascular risk² ³, a GP lipid check is sensible.
Here, treatment means consultant-led surgical excision. At Blue Fin Vision®, xanthelasma treatment in Hatfield is by surgical excision, carried out under local anaesthetic as a day case, with the plaque carefully excised and the skin closed to protect the eyelid contour⁴. Xanthelasma surgery by excision is recognised in the literature as a mainstay of treatment⁵. Your consultant confirms whether excision is appropriate for your lesions at assessment.
For a fuller explanation of the condition and how it is treated, see our guide to what is xanthelasma?.
Why Blue Fin Vision® in Hertfordshire
Our Hatfield service is delivered at One Hatfield Hospital, 3 Hatfield Avenue, Hatfield, Hertfordshire, AL10 9UA, by the same consultant-led team as our London clinics, under Mr Mfazo Hove, in CQC-registered facilities with a Doctify rating of 4.96 out of 5 from 557+ verified reviews.
Xanthelasma removal in Hatfield is carried out in a main operating theatre. This hospital setting adds to the cost compared with our clinic-based option at The Harley Street Eye Centre but saves patients across Hertfordshire a journey into London. Your consultant will help you choose the most appropriate and cost-effective setting.
Frequently Asked Questions
Where in Hertfordshire is treatment carried out?
At One Hatfield Hospital, 3 Hatfield Avenue, Hatfield, AL10 9UA.
Is xanthelasma harmful?
The plaques are benign, though they can be a marker of cardiovascular risk, so a lipid check is worthwhile².
Can both eyes be treated at once?
Often yes, depending on the number and position of the plaques; your consultant advises at assessment.
How long is recovery after xanthelasma removal?
Most people return to light activities within a few days, with redness or swelling settling within about a week.
Does xanthelasma removal removal improve vision?
Usually no. It is carried out for appearance and eyelid contour.
Book a consultant-led xanthelasma assessment at One Hatfield Hospital and receive a tailored plan, an exact price, and advice on whether lipid testing is appropriate.
Related Pages
References
- Nair PA, Singhal R. Xanthelasma palpebrarum: a brief review. Clin Cosmet Investig Dermatol. 2018;11:1-5.
- Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497.
- Dey A, Aggarwal R, Dwivedi S. Cardiovascular profile of xanthelasma palpebrarum. Biomed Res Int. 2013;2013:932863.
- Lee HY, Jin US, Minn KW, Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg. 2013;40(4):380-386.
- Yee DA, Zhou AE, Khachemoune A. Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities. Arch Dermatol Res. 2024;316(5):149.
ABOUT THE AUTHOR
Mr Mfazo Hove
MBChB MD FRCOphth CertLRS
Consultant Ophthalmic Surgeon | Founder and Medical Director, Blue Fin Vision®
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with more than two decades of experience across NHS and private practice and more than 57,000 ophthalmic procedures performed. He trained for six and a half years at Moorfields Eye Hospital and served for five years as an NHS consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust.
He specialises in cataract surgery, refractive lens replacement, laser vision correction and implantable Collamer lenses (ICL). He is the founder and Medical Director of Blue Fin Vision®, a private ophthalmology group providing consultant-delivered care across London, Hertfordshire and Essex. His cataract surgery outcomes are publicly reported through the National Ophthalmology Database.
A ZEISS Key Opinion Leader and international speaker, Mr Hove is a contributing author to The Ophthalmologist and Ophthalmology Times. His writing examines how clinical governance and the organisation of ophthalmic services shape patients’ experiences and outcomes, with a focus on transparent outcome reporting, surgical training and long-term accountability for patient care.
